| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/4/264:05 PM | -$0.76 | -$0.57GAAP | +25.0% | +51% | $1.2M | -$0.2M | -115% | -178% | |
| Q2 '26 | 8/5/264:05 PM | $0.88 | $0.47GAAP | -46.6% | +159% | $229.7M | $238.9M | +4.0% | ⚠ Check | |
| Q1 '26 | 5/6/264:05 PM | $0.38 | -$0.85GAAP | -324% | +3% | $122.5M | -$0.0M | -100% | -101% | |
| Q4 '25 | 2/23/265:15 PM | -$0.47 | -$0.31GAAP | +34.0% | +59% | $19.4M | $64.1M | ⚠ Check | +418% | |
| Q3 '25 | 11/5/254:05 PM | -$0.80 | -$1.17GAAP | -46.2% | +25% | $4.0M | $0.2M | ⚠ Check | -90% | |
| Q2 '25 | 8/6/254:05 PM | -$0.72 | -$0.80GAAP | -11.1% | +22% | $4.7M | $1.2M | ⚠ Check | -61% | |
| Q1 '25 | 5/7/254:05 PM | -$0.84 | -$0.88GAAP | -4.8% | -83% | $8.6M | $3.0M | ⚠ Check | ⚠ Check |
⚠ Potential error in calculation, check manually. The two revenue figures may be in different units or currencies.
GAAP = diluted EPS as filed with the SEC.